No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs7792487 |
chr7:12840090-12840091 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs556873958 |
chr7:12840127-12840128 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs189964481 |
chr7:12840201-12840202 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs543818170 |
chr7:12840205-12840206 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs542422243 |
chr7:12840220-12840221 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs559174925 |
chr7:12840237-12840238 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs375248100 |
chr7:12840250-12840251 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs572822027 |
chr7:12840254-12840255 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs73064127 |
chr7:12840255-12840256 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs564535940 |
chr7:12840262-12840263 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs529990413 |
chr7:12840271-12840272 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs377124240 |
chr7:12840316-12840317 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs565340680 |
chr7:12840403-12840404 |
Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs182266233 |
chr7:12840410-12840411 |
Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs529463568 |
chr7:12840435-12840436 |
Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs368327257 |
chr7:12840468-12840469 |
Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs546933936 |
chr7:12840487-12840488 |
Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs186457615 |
chr7:12840510-12840511 |
Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs115184894 |
chr7:12840514-12840515 |
Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs372311559 |
chr7:12840523-12840524 |
Weak transcription Flanking Active TSS Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs571268706 |
chr7:12840557-12840558 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs536738321 |
chr7:12840563-12840564 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs556597649 |
chr7:12840566-12840567 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs532657868 |
chr7:12840582-12840583 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs13233019 |
chr7:12840583-12840584 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs34150302 |
chr7:12840645-12840646 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs536010603 |
chr7:12840785-12840786 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs140586176 |
chr7:12840787-12840788 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs190916872 |
chr7:12840798-12840799 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs545312514 |
chr7:12840802-12840803 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs111400858 |
chr7:12840805-12840806 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs577932019 |
chr7:12840845-12840846 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs12538097 |
chr7:12840867-12840868 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs563745912 |
chr7:12840960-12840961 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs552395671 |
chr7:12840971-12840972 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs149728143 |
chr7:12841038-12841039 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs145560137 |
chr7:12841048-12841049 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs73292080 |
chr7:12841054-12841055 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs560016284 |
chr7:12841098-12841099 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs528778303 |
chr7:12841108-12841109 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs148862774 |
chr7:12841153-12841154 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs571856460 |
chr7:12841199-12841200 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs12538194 |
chr7:12841215-12841216 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs373708872 |
chr7:12841218-12841219 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs7797619 |
chr7:12841226-12841227 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs535975004 |
chr7:12841253-12841254 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs552724783 |
chr7:12841270-12841271 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs189040971 |
chr7:12841284-12841285 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs538466823 |
chr7:12841285-12841286 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs12538763 |
chr7:12841380-12841381 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|